Viewing nowRosabel Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
PalmGen Science Co., Ltd.

MFDS item code 200502026 · Notified 2005.03.28 · Insurance code 670100290
Treatment of hypertension and hypertensive nephropathy associated with type 2 diabetes
This medication is used to treat hypertension. It is especially effective in patients with type 2 diabetes who also develop kidney disease. It helps control blood pressure, thereby protecting cardiovascular and kidney function. Therefore, it is useful for the treatment of hypertension and related kidney complications.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age or older weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age or older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to patients with certain conditions, including those allergic to this drug or its components, pregnant women or women who may become pregnant, patients with severe liver impairment, patients with hereditary angioedema, and patients with primary hyperaldosteronism. Additionally, careful administration is required for certain patients, including the elderly, those with hyperkalemia, patients with liver impairment, patients with heart valve diseases, patients with decreased blood volume, and patients with severely reduced kidney function. Generally, this medication is well-tolerated; however, side effects such as muscle cramps, back pain, dizziness, and upper respiratory infections may occur, and rarely, serious side effects such as angioedema, liver function abnormalities, renal failure, or hypotension have been reported. Particular caution should be exercised when driving or operating machinery due to dizziness or orthostatic hypotension from blood pressure-lowering effects. This medication may interact with other drugs, so caution is advised when taken with potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, etc., and consultation with a physician is necessary. Pregnant and breastfeeding women should avoid taking this medication, especially during pregnancy, due to potential risks to the fetus, and should consult a doctor to make a decision on whether to take it. In pediatric patients, it should not be administered to those under 6 years or with severely reduced kidney function. In cases of overdose, hypotension and bradycardia may occur, requiring immediate medical attention. During the course of treatment, regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary, and consultation with a physician should occur if any abnormal symptoms arise. Finally, this medication should be stored out of the reach of children, and transferring it to another container should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best stored at room temperature between 1 and 30 degrees Celsius.
White oval film-coated tablets
300 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
PalmGen Science Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.